As the downstream effector of Notch signaling, NOTCH-Regulated Ankyrin Repeat Protein (NRARP) that can be activated by NOTCH pathway was previously reported to be over-expressed in some cancers like breast cancer and liver cancer [10, 11]. This evidence concerns the gene NRARP and cancer.